IDO1 and neoplasm: Further application of 11C-l-1MTrp to monitor therapeutic efficacy in mice treated with one of two IDO1 blockade + chemotherapy regimens showed little ability to distinguish between good and poor responders via tumor PET imaging (figures 2 and 3A); a similar phenomenon was reported in a previous study.30